GI Portfolio I/ DE000A0KDYE3 /
NAV22/08/2024 | Chg.-91.3496 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
20,900.2500EUR | -0.44% | reinvestment | Mixed Fund Worldwide | Union Inv. Privatf. ▶ |
GlobeNewswire
02/03/2022
Gastro Care Partners Taps Fujifilm to Deliver Best in Breed Endoscopic Imaging Solutions to GI Pract...
GlobeNewswire
18/04/2018
Gastrointestinal, Laparoscopy and Urology Applications Drive the Demand for Endoscopy Devices to Rea...
GlobeNewswire
05/03/2018
Shire plc : U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic C...
GlobeNewswire
05/03/2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation